FDA Warns Of Clip Lock Risk With Abbott's MitraClip

The US FDA is alerting providers about a potential clip lock malfunction with Abbott’s MitraClip, a device used to treat a disorder involving the heart’s mitral valve.  

Abbott Labs Phone
• Source: Shutterstock

Health care providers using a device from Abbott Laboratories to stop heart valve leakage should be on the lookout for a malfunction that can lead to heart attack, stroke, or death.

More from Regulation

More from Policy & Regulation